The last time I wrote an article on Sana Biotechnology (SANA) it was with respect to an article entitled "Sana: Major Inflection Point For SC291 In 2025 Targeting Lupus". It is still set to release ...
Share on Pinterest Researchers are looking into treatments for type 1 diabetes that don’t involve insulin. Natasha Lazaridi/Getty Images Researchers from the University at Buffalo are hoping that ...
Teplizumab, a humanized monoclonal antibody to CD3 on T cells, is approved by the Food and Drug Administration to delay the onset of clinical type 1 diabetes (stage 3) in patients 8 years of age or ...
Treatment with the diabetes and weight loss drug semaglutide may allow people newly diagnosed with Type 1 diabetes to dramatically cut back or even completely stop insulin injections, a very small ...
Use of the drug verapamil to treat Type 1 diabetes continues to show benefits lasting at least two years, researchers report in the journal Nature Communications. Patients taking the oral blood ...
Tahirah is a public health professional with more than 10 years experience supporting people along various stages of their health journey. She has a Master of Public Health in epidemiology and ...
BUFFALO, N.Y.— Treating newly diagnosed Type 1 diabetes patients with semaglutide (trade names Ozempic, Wegovy and Rybelsus) may drastically reduce or even eliminate their need for injected insulin.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback